8-K: Ekso Bionics to Merge with Applied Digital Cloud for AI

Ekso Bionics announced a non-binding term sheet to combine with Applied Digital's cloud business, forming ChronoScale Corporation, an AI compute platform.

Summary

• Ekso Bionics Holdings, Inc. (EKSO) and Applied Digital Corporation (Applied) entered into a non-binding term sheet for a business combination.
• Applied Digital's cloud computing business, Applied Digital Cloud, will combine with EKSO to form ChronoScale Corporation.
• ChronoScale will be an accelerated compute platform purpose-built to support artificial intelligence (AI) workloads.
• Upon closing, Applied Digital is expected to own approximately 97% of ChronoScale, while EKSO's existing stockholders would own approximately 3%.
• The 3% ownership for EKSO stockholders is subject to proportional dilution by any equity financing occurring at closing.
• EKSO plans to explore strategic transactions for the possible sale of its current exoskeleton business.
• The transaction is subject to customary due diligence, definitive agreements, regulatory and stockholder approvals, and closing conditions.

Sentiment

Score: 4

Explanation: While the move into AI compute is strategically sound and targets a high-growth market, the severe dilution for existing EKSO shareholders (3% ownership, potentially less) and the non-binding nature of the agreement introduce significant uncertainty and negative immediate impact on current equity value. The potential sale of EKSO's core business also signals a complete pivot.

Positives

• The Proposed Transaction aims to create a focused platform, ChronoScale, designed to deliver high-performance compute at scale in a capacity-constrained market for AI workloads.
• Separating the accelerated compute platform from Applied Digital's data center business allows each to scale independently with greater strategic and capital flexibility.
• ChronoScale is expected to leverage Applied Digital Cloud's mature business, which deployed NVIDIA H100 GPUs at scale in 2023, demonstrating early adoption capabilities.
• Applied Digital Cloud generated approximately $75.2 million in revenue for the twelve months ending August 31, 2025, indicating strong demand.
• ChronoScale is expected to benefit from strategic alignment with Applied Digital's AI factory campuses, providing advantaged access to infrastructure and reducing deployment risks.
• EKSO's CEO believes the transaction has the potential to maximize shareholder value and is in the best interest of stakeholders.

Negatives

• Existing EKSO stockholders are expected to own only approximately 3% of the combined company, ChronoScale, upon closing.
• This 3% ownership is subject to proportional dilution by any equity financing that occurs in connection with the closing.
• The term sheet is non-binding, and there are no assurances that definitive agreements will be reached or that the Proposed Transaction will be consummated on the contemplated terms or timeframe, or at all.
• EKSO's current business is planned for a possible sale, indicating a complete shift away from its core exoskeleton technology.

Risks

• The parties' ability to complete due diligence and negotiate and execute definitive documentation for the Proposed Transaction.
• EKSO's ability to successfully sell its existing business.
• The parties' ability to close the Proposed Transaction.
• Difficulties and delays in integrating the combined business resulting from the Proposed Transaction.
• Higher than anticipated transaction costs.
• The parties' ability to realize the contemplated financial, business, or strategic benefits associated with the Proposed Transaction.
• The parties' ability to obtain regulatory and stockholder approval for the Proposed Transaction.
• The ability of the combined business to retain key customers, employees, and relationships.
• Changes to AI and High Performance Computing infrastructure needs and their impact on future plans.
• The parties' ability to raise additional capital to fund the combined company's business plan.
• Dependence on a small number of principal customers.
• Power or other supply disruptions and equipment failures.
• The parties' inability to comply with regulations, developments, and changes in regulations.
• Cash flow and access to capital.
• Availability of project and other financing to grow the combined company.
• Decline in demand for the combined company's products and services.
• Maintenance of third-party relationships.
• Conditions in the debt and equity capital markets.

Future Outlook

The combined entity, ChronoScale Corporation, is being designed as an accelerated compute platform purpose-built to support demanding AI workloads, leveraging Applied Digital Cloud's proven operating platform and early adoption of next-generation GPU infrastructure. The transaction is expected to close in the first half of 2026, subject to various conditions. EKSO also plans to explore the sale of its current exoskeleton business.

Management Comments

• "We approached our review thoughtfully and with an aim to maximize shareholder value, and we believe the Proposed Transaction has the potential to achieve that goal and that the Proposed Transaction is in the best interest of EKSOs stakeholders." Scott Davis, EKSO's Chief Executive Officer.
• "ChronoScale is intended to bring together a proven operating platform and a clear mandate: deliver accelerated compute at scale for the most demanding AI workloads." Wes Cummins, Chairman and Chief Executive Officer of Applied Digital.
• "As AI workloads continue to reshape the digital economy and intensify, infrastructure must be purpose-built, not generalized – and ChronoScales design is intended to meet these requirements." Wes Cummins, Chairman and Chief Executive Officer of Applied Digital.

Industry Context

This transaction reflects the rapidly growing demand for GPU-accelerated cloud infrastructure driven by enterprise and AI-native applications. The formation of ChronoScale aims to address the capacity-constrained market for high-performance compute at scale, aligning with the industry trend towards specialized, purpose-built infrastructure for advanced AI training and inference workloads. Applied Digital Cloud's prior deployment of NVIDIA H100 GPUs positions ChronoScale to capitalize on this trend.

Comparison to Industry Standards

• Applied Digital Cloud was among the first platforms to deploy NVIDIA's H100 GPUs at scale in 2023, demonstrating an ability to source, integrate, and operate next-generation GPU infrastructure ahead of broader market adoption. This indicates a competitive advantage in rapid technology deployment compared to generic cloud environments.
• ChronoScale's design for predictable performance, infrastructure control, and rapid deployment without the tradeoffs of generic cloud environments positions it against broader cloud providers by offering specialized, optimized solutions for demanding AI workloads.
• The strategic alignment with Applied Digital's expanding portfolio of purpose-built AI factory campuses provides advantaged access to infrastructure, potentially accelerating deployment timelines and reducing execution risks compared to competitors reliant on less integrated or optimized infrastructure.

Stakeholder Impact

• Shareholders (EKSO): Significant dilution of ownership (expected 3% of combined company, subject to further dilution), potential for value creation through exposure to high-growth AI compute market, but also uncertainty regarding the sale of the existing exoskeleton business.
• Shareholders (Applied Digital): Expected to own approximately 97% of the combined company, gaining a focused AI compute platform, potentially enhancing value by separating the cloud business.
• Employees (EKSO): Uncertainty regarding the future of the exoskeleton business and potential changes in roles or employment as the company pivots.
• Customers (EKSO): Potential disruption or change in service/product availability for exoskeleton solutions if the business is sold or divested.
• Customers (Applied Digital Cloud): Expected to benefit from a more focused and optimized accelerated compute platform (ChronoScale) designed for demanding AI workloads.

Next Steps

• Completion of customary due diligence by both parties.
• Negotiation and execution of final binding documents.
• Obtaining customary regulatory approvals.
• Obtaining stockholder approvals for the Proposed Transaction.
• Satisfaction of closing conditions.
• ChronoScale expects to file a Registration Statement on Form S-4 (or EKSO a standalone proxy statement) with the SEC.
• EKSO plans to continue exploring strategic transactions for the possible sale of all or substantially all of its current business.
• Expected closing of the Proposed Transaction in the first half of 2026.

Key Dates

Recommendation

The proposed business combination results in severe dilution for existing Ekso Bionics shareholders, who are expected to own only 3% of the combined entity, ChronoScale, with potential for further dilution from future equity financing. While the pivot to the high-growth AI compute market is strategically sound, the terms of the deal heavily favor Applied Digital, and the non-binding nature introduces significant execution risk. Current shareholders are essentially being cashed out at a very low percentage of the new venture, making it prudent to sell and re-evaluate investment in the new entity if desired.

Keywords

Ekso Bionics, Applied Digital, ChronoScale, AI, Artificial Intelligence, Cloud Computing, GPU, Business Combination, Merger, Technology, Data Centers, High Performance Computing, Exoskeleton